Litigation

Patent suit against Biocon- Keeping Galvus in check…

Leave a Comment / April 2014, Newsletter / By ipmetrix / Biocon, Litigation, Novartis, Vildagliptin

The most famous drug for diabetes, Galvus also known as Vildagliptin is under patent litigation. Swiss drug maker Novartis has filed an infringement proceeding against Biocon, the Bangalore-based Company and Asia\’s largest insulin maker on Galvus or Vildagliptin, a DPP4 inhibitor class of drugs used to treat type-2 diabetes. Novartis filed the case on 27 …

Patent suit against Biocon- Keeping Galvus in check… Read More »

Patent Litigation Jackpot:

Leave a Comment / April 2014, Newsletter / By ipmetrix / Carnegie Mellon University, Litigation, Marvell Technology Group Limited

Marvell Technology Group Limited, the leading producer of Storage, communication products is entangled in a major patent Litigation case against a private Research University, Carnegie Mellon University (CMU). The federal court ordered Marvell to pay $1.5 Billion as enhanced penalties for deliberately infringing Carnegie’s Intellectual Property, the third largest ever in a patent case at …

Patent Litigation Jackpot: Read More »

What is your IP portfolio? ipMetrix provides value-added research and strategy for all IP classes.